摘要 |
The present disclosure provides an isolated protein comprising at least one antibody variable region that is capable of binding to peptidase inhibitor 16 (PI16), wherein the protein is also capable of competitively inhibiting binding of an antibody produced by a hybridoma designated CRCBT-02-001 deposited with the ATCC under Accession Number PTA-10685 to PI16. The present invention also provides use of the protein, e.g., in diagnosis, therapy or to isolate cells, preferably Treg cells. |
申请人 |
TRANSBIO LTD;BARRY, SIMON;KRUMBIEGEL, DOREEN;EASTAFF-LEUNG, NICOLA GA-LING;NICHOLSON, IAN, CAMERON;ZOLA, HEDDY |
发明人 |
BARRY, SIMON;KRUMBIEGEL, DOREEN;EASTAFF-LEUNG, NICOLA GA-LING;NICHOLSON, IAN, CAMERON;ZOLA, HEDDY |